
GENOA PHARMACEUTICALS is a biopharmaceutical company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe pulmonary diseases. Genoa's lead program (Aerodone™; inhaled pirfenidone) is on track to enter clinical development by year’s end.
Member count: 1-10
Total raised: $63.2M
Founded date: 2011
Investors 1
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
15.05.2017 | Series A | $62M | - | finsmes.co... |
08.11.2012 | - | $1.2M | - | socaltech.... |
Mentions in press and media 5
Date | Title | Description | Category | Author | Source |
15.05.2017 | Term Sheet... | A THOROUGH GENTLEMAN The stra... | - | - | fortune.co... |
15.05.2017 | Genoa Phar... | - | - | - | fprimecapi... |
15.05.2017 | Genoa Phar... | SEATTLE, WA, Biopharmaceutic... | - | - | vcnewsdail... |
15.05.2017 | Genoa Phar... | Genoa Pharmaceuticals, Inc., a... | USA | - | finsmes.co... |
08.11.2012 | Genoa ... | San Diego-based biotechnology ... | - | - | socaltech.... |